PMC:7696151 / 23721-23876 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7696151","sourcedb":"PMC","sourceid":"7696151","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7696151","text":"and divided into two groups; the control group treated with standard-of-care (SOC) consisted of 160 µg of subcutaneous pegylated interferon and 1000–12000 ","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"712","span":{"begin":119,"end":139},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"attributes":[{"subj":"712","pred":"source","obj":"LitCovid-PubTator"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93acec","default":true}]}]}}